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Stem cell self-renewal is intrinsically associated with cell cycle control. However, the precise mechanisms
coordinating cell fate choices and cell cycle remain to be fully uncovered. Now in Cell, Gonzales et al.
(2015) and colleagues demonstrate that factors controlling the G2/M phase are necessary to block pluripo-
tency upon induction of differentiation.Stem cells are defined by their ability to
proliferate almost indefinitely while main-
taining their capacity to differentiate into
several cell types. The coordination of
these two properties, self-renewal and
multipotency, is essential to ensure
proper embryonic development, organo-
genesis, organ homeostasis, and tissue
repair upon injury. Furthermore, uncon-
trolled proliferation of stem cells could
play a major role in diseases such as can-
cer. Thus, understanding the interplay
between cell-cycle regulation and cell
fate decisions represents a major interest
for the stem cell field. Nonetheless, the
study of these mechanisms has been
restricted by the technical difficulties
impairing investigations of cell-cycle reg-
ulations in vivo and also by the lack of
appropriate in vitro model systems. Now
in Cell, Huck-Hui Ng and colleagues
demonstrate that pluripotency of human
embryonic stem cells (hESCs) is con-
trolled by factors necessary for the
transition of the G2/M phase of the cell
cycle. This study provides new insights
into the mechanisms by which stem cells
exploit cell-cycle machinery to control
their cell fate decisions (Gonzales et al.,
2015).The cell cycle can be divided into four
different phases: the G1 phase, during
which a cell decides to engage in a new
division; the S phase, when DNA is repli-
cated; the G2 phase, which allows DNA
repair mechanisms; and the M phase, at
the end of which cells divide. The G1
phase has been the focus of a broad num-
ber of studies on stem cells since cell fate
choices seems to occur or at least be initi-
ated during this part of the cell cycle.
Indeed, several reports have shown that
stem cells can perceive differentiation sig-
nals specifically in G1. Of particular inter-
est, the early G1 phase is permissive
for endoderm differentiation in hESCs
while the late G1 phase is only permis-
sive for neuroectoderm specification
(Pauklin and Vallier, 2013). This divergent
capacity of differentiation is established
by CyclinD/CDK4-6, which are expressed
during the late G1 phase. These cell-cycle
regulators inhibit the Activin/Nodal sig-
naling pathway, which is known to block
neuroectoderm differentiation of hESCs
while being necessary for endoderm dif-
ferentiation. Importantly, the importance
of the G1 phase and CyclinD/CDK4-6
appear to be conserved in adult stem cells
(Lange et al., 2009; Mende et al., 2015).Thus, the cell-cycle machinery could
directly orchestrate initiation of differenti-
ation during the G1 phase progression in
a diversity of cell types.
The importance of S/G2 in stem cell
control is by far less explored. Regulators
of these phases of cell cycle such as
Cyclin B1 are necessary for cell survival
and their absence often results in cell
death and/or major genomic anomalies.
For these reasons, the importance of
the G2 phase in stem cell self-renewal
and differentiation remains to be fully un-
covered. The report by Gonzales et al.
(2015) remedies this shortfall by revealing
that the G2 transition could also have a
key function in the mechanisms directing
hESC differentiation.
The authors first performed an siRNA
screen to identify factors that could delay
differentiation induced by the absence or
inhibition of TGFb/Activin/Nodal and FGF
signaling, both of which are known to
be essential for the pluripotent state of
hESCs (Thomson et al., 1998; Vallier
et al., 2004). This screen revealed that
several epigenetic mechanisms such as
histone acetylation and chromatin remod-
eling are essential for the transition be-
tween pluripotency and differentiation to7, August 6, 2015 ª2015 Elsevier Inc. 131
Figure 1. Cell Fate Specification Starts in the G1 Phase When hESCs Can Sense
Differentiation Signals
Cell fate commitment is only achieved in G2/M, when pluripotency is dissolved through cell-cycle-depen-
dent mechanisms. Control of G2/M factors and subsequently absence of ART/ATM is necessary for this
process.
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Previewsoccur normally. The enrichment in cell-
cycle genes controlling DNA replication
and G2 phase was less expected. To
further validate these observations, the
authors used either shRNA or small-mole-
cule inhibitors to block regulators of each
phase of the cell cycle during sponta-
neous differentiation of hESCs provoked
by the absence of TGFb and FGF. These
experiments showed that regulators of
the S and G2 phases are necessary for
rapid decrease of pluripotency upon in-
duction of differentiation in these culture
conditions. Knockdown of regulators of
the G1 phase such as CDK4/6 or CyclinD
had little effect on pluripotency markers,
thereby confirming the S/G2 specificity
of these results. Further investigations re-
vealed that the DNA damage checkpoint
factors ATR/ATM participate directly in
these mechanisms by enhancing the ac-
tivity of the TGFb/Activin/Nodal path-
way through p53 during S and G2.
The upregulation of TGFb then delays
the decrease in the expression of pluripo-
tency markers.
Considered together, these results
imply that induction of differentiation oc-
curs during the G1 phase while loss of
pluripotency is achieved subsequently in
S and G2. This model (Figure 1) could
explain how cell fate specification and
cell fate commitment can be achieved
during cell-cycle progression upon differ-
entiation. Indeed, hESCs could engage
toward differentiation in early G1 and
then decide only in G2 to fully commit
toward a specific lineage by dissolving
their pluripotent state. This model is in
agreement with the notion that major132 Cell Stem Cell 17, August 6, 2015 ª2015epigenetic events occur during S phase.
Indeed, inheritance of DNA methylation
and histone marks in daughter cells oc-
curs during the S and G2 phases, respec-
tively. Thus, it would be rational for stem
cells to change their cellular identity dur-
ing these phases of the cell cycle when
epigenetic marks are established.
However, these new results also raise
several important questions. The involve-
ment of a DNA repair checkpoint is
intriguing since these mechanisms are
associated with exposure to agents
damaging DNA. The molecular link be-
tween these mechanisms, i.e., normal
cell-cycle progression and cell fate deci-
sions, remains to be fully uncovered. An
intriguing possibility could be that incom-
plete differentiation signals activate the
ATR/ATM response, which in turn rein-
forces pluripotency to avoid the produc-
tion of ‘‘abnormal’’ cells. This hypothesis
could be validated by the confirmation
that the mechanisms described by the
current study function during directed
differentiation of hESCs into cells repre-
sentative of the three germ layers.
Furthermore, induction of differentiation
and loss of pluripotency represent two
aspects of the same process and are
intrinsically linked. Indeed, differentiation
of hESCs is orchestrated by the coopera-
tion of pluripotency factors and develop-
mental regulators (Radzisheuskaya et al.,
2013; Teo et al., 2011), while signaling
pathway such as TGFb signaling are often
necessary to maintain the transcriptional
network characterizing both the pluripo-
tent and differentiated state (Brown
et al., 2011). Thus, the transition betweenElsevier Inc.pluripotent and differentiating cells is
likely to be controlled by complex and in-
terlinked molecular mechanisms during
cell-cycle progression upon differentia-
tion. Finally, an important challenge will
be to demonstrate that such mechanisms
are relevant for natural development and
adult stem cells. Indeed, further studies
will be necessary to demonstrate that
perturbation of the ATR/ATM pathway
can modify the differentiation capacity of
adult stem cells. If true, these mecha-
nisms could provide a new approach to
control stem cell potency in vivo.
Thus, the current report represents an
important step toward the understanding
of the interplays between cell cycle regu-
lation and cell fate decisions in stem cells.
Such knowledge could be essential to
control stem cell potency not only
in vitro but also in vivo in the context of
organ regeneration and disease.ACKNOWLEDGMENTS
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